Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil P Robertson

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Journal of Neurology|May 16, 2018
Monoclonal antibodies for migraine: an updateDaniel Castle, Neil P Robertson
Journal of Neurology|March 22, 2013
Antibody mediated encephalitisGillian Ingram, Neil P Robertson
Journal of Neurology|October 12, 2014
Accurate diagnosis of inflammatory neuropathiesGillian Ingram, Neil P Robertson
Expert Opinion on Drug Safety|June 18, 2014
Drug safety evaluation of alemtuzumab for multiple sclerosisMark Willis, Neil P Robertson
Journal of Neurology|August 1, 2022
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatmentKarim L Kreft, Neil P Robertson
Journal of Neurology|August 28, 2016
The consequences of valproate exposure in uteroRhys H Thomas, Neil P Robertson
Journal of Neurology|July 24, 2020
Emerging treatments for neuromyelitis optica spectrum disorderRay Wynford-Thomas, Neil P Robertson
Therapeutics and Clinical Risk Management|April 8, 2015
Alemtuzumab for the treatment of multiple sclerosisMark D Willis, Neil P Robertson
Journal of Neurology|September 17, 2014
Novel auto-antibody syndromesRhys H Thomas, Neil P Robertson
Journal of Neurology|February 6, 2016
New ways of looking at an old disease: the reimagination of epilepsyClinton J Mitchell, Neil P Robertson
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Journal of Neurology|May 16, 2018
Monoclonal antibodies for migraine: an updateDaniel Castle, Neil P Robertson
Journal of Neurology|March 22, 2013
Antibody mediated encephalitisGillian Ingram, Neil P Robertson
Journal of Neurology|October 12, 2014
Accurate diagnosis of inflammatory neuropathiesGillian Ingram, Neil P Robertson
Expert Opinion on Drug Safety|June 18, 2014
Drug safety evaluation of alemtuzumab for multiple sclerosisMark Willis, Neil P Robertson
Journal of Neurology|August 1, 2022
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatmentKarim L Kreft, Neil P Robertson
Journal of Neurology|August 28, 2016
The consequences of valproate exposure in uteroRhys H Thomas, Neil P Robertson
Journal of Neurology|July 24, 2020
Emerging treatments for neuromyelitis optica spectrum disorderRay Wynford-Thomas, Neil P Robertson
Therapeutics and Clinical Risk Management|April 8, 2015
Alemtuzumab for the treatment of multiple sclerosisMark D Willis, Neil P Robertson
Journal of Neurology|September 17, 2014
Novel auto-antibody syndromesRhys H Thomas, Neil P Robertson
Journal of Neurology|February 6, 2016
New ways of looking at an old disease: the reimagination of epilepsyClinton J Mitchell, Neil P Robertson
Pageof 13